A Pennsylvania county has acknowledged that tests it purchased from a local biotech start-up produced “potentially inaccurate†results for thousands of people.
Chester County vowed this week to reach out to those who received the “questionable test results†in late May and to appoint a consultant to review the purchase of the antibody tests, The Philadelphia Inquirer reported.
In the first few weeks after testing began May 7, the tests produced results that appeared to be accurate.
The county, though, never informed those who may have received false alarms, nor did it disclose the questionable results — about 6,100 of the 19,425 tests it conducted — on its website.
Chester County said Tuesday that its three-member Board of Commissioners would appoint an “independent legal consultant†to review the process associated with sourcing and procuring the antibody tests.
UK
Australia
France
Germany
Russia
India
Canada